Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent Nav1.8 channel blockers July 27, 2020
JAK1 inhibitor CJ-14939 may be a potential adjuvant for NSCLC patients with erlotinib resistance July 27, 2020
QF-036, a new HIV maturation inhibitor, shows no toxicity in single or repeated dose studies in rats July 27, 2020
RSS